Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98.7M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
136M
-
Shares change
-
-3.48M
-
Total reported value, excl. options
-
$633M
-
Value change
-
-$16.4M
-
Put/Call ratio
-
0.72
-
Number of buys
-
73
-
Number of sells
-
-90
-
Price
-
$4.66
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q4 2022
209 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q4 2022.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136M shares
.
Largest 10 shareholders include Francisco Partners Management, LP (84.7M shares), VANGUARD GROUP INC (7.83M shares), MILLENNIUM MANAGEMENT LLC (5.32M shares), Silver Lake Group, L.L.C. (3.53M shares), MARSHALL WACE, LLP (3.27M shares), Petrus Trust Company, LTA (2.44M shares), BlackRock Inc. (2.19M shares), RENAISSANCE TECHNOLOGIES LLC (1.91M shares), Technology Crossover Management X, Ltd. (1.65M shares), and TWO SIGMA INVESTMENTS, LP (1.57M shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.